Related Experiment Videos
A nuclear RNA-binding cyclophilin in human T cells
1Institut für Biochemie und Molekularbiologie der Albert-Ludwigs-Universität, Freiburg, Germany.
FEBS Letters
|December 2, 1996
Summary
Researchers discovered a novel human nuclear cyclophilin (hCyP33) in T cells. This protein uniquely combines RNA binding and protein folding activities, expanding the known functions of cyclophilins.
Area of Science:
- Molecular Biology
- Immunology
- Cell Biology
Background:
- Cyclophilins (CyPs) are conserved proteins with peptidyl-prolyl cis-trans isomerase (PPIase) activity.
- CyPs are known to bind the immunosuppressive drug cyclosporin A (CsA) and are involved in protein folding and interactions.
- Current knowledge indicates CyPs interact only with cyclosporins and other proteins.
Purpose of the Study:
- To identify and characterize novel cyclophilins in human cells.
- To investigate the functional domains and potential new roles of cyclophilins.
Main Methods:
- Identification of a novel nuclear cyclophilin (hCyP33) from human T cells.
- Analysis of the protein's domain structure and enzymatic activity.
Main Results:
- A novel nuclear cyclophilin, hCyP33, was identified in human T cells.
- hCyP33 possesses an RNA-binding domain in addition to its PPIase activity.
- This represents the first described protein combining both RNA binding and protein folding capabilities.
Conclusions:
- The discovery of hCyP33 expands the known functional repertoire of cyclophilins.
- This novel protein integrates RNA binding and protein folding, suggesting new roles in cellular processes.
- hCyP33 offers a unique molecular tool for studying RNA-protein interactions and protein folding pathways.